Mianserin reduces plasma levels ofβ-endorphin immunoreactivity in depressed patients
- 1 June 1982
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 38 (6) , 685-686
- https://doi.org/10.1007/bf01964095
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Cerebrospinal fluid endorphins in schizophreniaActa Psychiatrica Scandinavica, 1980
- Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.Proceedings of the National Academy of Sciences, 1978
- MianserinDrugs, 1978
- Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat.American Journal of Physiology-Endocrinology and Metabolism, 1978
- Naloxone (Narcan®) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolitesPsychopharmacology, 1977
- Increased CSF levels of endorphines in chronic psychosisNeuroscience Letters, 1976
- International reliability and communicability of a rating scale for depressionPsychological Medicine, 1973
- Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).1972